New hope for young adults battling leukemia: early trial tests safer chemo combo
NCT ID NCT05581030
Summary
This early-stage study is testing whether adding a new drug called calaspargase pegol to standard chemotherapy is safe for young adults newly diagnosed with acute lymphoblastic leukemia. Researchers will monitor 7 participants closely for side effects and early signs of how well the treatment works. The goal is to see if this combination can help control the cancer while being tolerable for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.